← All trials
NCT04335045
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 25, 2013
- Primary completion
- Dec 8, 2014
- Completion date
- Dec 8, 2014
- First posted
- Apr 6, 2020
- Last posted
- Apr 6, 2020
- Enrollment
- 48
- Arms / groups
- 12 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Phloronol Inc.Lead sponsor
- World Wide Clinical Trials Early Phase Services, LLCOverall official - principal investigator
- Worldwide Clinical TrialsCollaborator
Drugs studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.